Penumbra Price to Book Ratio 2014-2022 | PEN

Historical price to book ratio values for Penumbra (PEN) over the last 10 years. The current price to book ratio for Penumbra as of February 03, 2023 is 10.18.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Penumbra Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2023-02-03 261.02 10.18
2022-09-30 189.60 $25.65 7.39
2022-06-30 124.52 $25.60 4.86
2022-03-31 222.13 $25.47 8.72
2021-12-31 287.32 $25.39 11.32
2021-09-30 266.50 $18.33 14.54
2021-06-30 274.06 $18.41 14.89
2021-03-31 270.58 $17.83 15.18
2020-12-31 175.00 $17.51 9.99
2020-09-30 194.38 $17.07 11.39
2020-06-30 178.82 $17.29 10.34
2020-03-31 161.33 $13.92 11.59
2019-12-31 164.27 $13.87 11.84
2019-09-30 134.49 $13.38 10.06
2019-06-30 160.00 $13.06 12.25
2019-03-31 147.01 $12.63 11.64
2018-12-31 122.20 $12.27 9.96
2018-09-30 149.70 $11.86 12.62
2018-06-30 138.15 $12.37 11.17
2018-03-31 115.65 $12.11 9.55
2017-12-31 94.10 $11.89 7.92
2017-09-30 90.30 $11.31 7.98
2017-06-30 87.75 $11.04 7.95
2017-03-31 83.45 $11.11 7.51
2016-12-31 63.80 $8.57 7.45
2016-09-30 75.99 $8.02 9.47
2016-06-30 59.50 $7.97 7.46
2016-03-31 46.00 $7.75 5.93
2015-12-31 53.81 $7.78 6.92
2015-09-30 40.10 $7.65 5.24
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.913B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00